MedPath

Mundipharma (China) Pharmaceutical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Phase 3
Completed
Conditions
Cancer
Pain
Interventions
Drug: Oxycodone/Naloxone
First Posted Date
2013-06-24
Last Posted Date
2019-10-04
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
232
Registration Number
NCT01885182
Locations
🇨🇳

The sixth hospital of shanghai, Shanghai, China

🇨🇳

Tianjin Cancer Hospital, Tianjin, China

🇨🇳

Beijing Friendship Hospital, Beijing, China

and more 25 locations

OxyNorm Capsules in Post-Operative Pain Study

Phase 3
Completed
Conditions
Postoperative Pain
Interventions
Drug: OxyNorm Capsules
Other: Morphine tablet
First Posted Date
2012-08-30
Last Posted Date
2018-02-26
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
240
Registration Number
NCT01675635

Immediate-Release Oxycodone Capsules Study in Cancer Pain

Phase 3
Completed
Conditions
Cancer
Interventions
First Posted Date
2012-08-30
Last Posted Date
2018-05-21
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
242
Registration Number
NCT01675622

Norspan Transdermal Patches Study in Osteoarthritis Patients

Phase 1
Completed
Conditions
Osteoarthritis Disorders
Interventions
First Posted Date
2012-07-18
Last Posted Date
2015-07-08
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
30
Registration Number
NCT01643759
Locations
🇨🇳

Investigational Site: Peking Union Medical Hospital(PUMC), Beijing, China

OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study

Phase 1
Completed
Conditions
Pain
Interventions
First Posted Date
2012-07-18
Last Posted Date
2019-10-21
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
61
Registration Number
NCT01643772
Locations
🇨🇳

Affiliated Hospital to Academy of Military Medical Science of China People's Liberation Army, Beijing, China

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Phase 1
Completed
Conditions
Pain
Interventions
First Posted Date
2011-12-01
Last Posted Date
2015-08-11
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
44
Registration Number
NCT01482936
Locations
🇨🇳

Investigational Site: Affiliated Hospital to Academy of Military Medical Science of China People's Liberation Army, Beijing, China

NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

Phase 3
Completed
Conditions
Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)
Interventions
First Posted Date
2011-11-22
Last Posted Date
2015-07-08
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
280
Registration Number
NCT01476774
Locations
🇨🇳

Investigational Site:Peking Union Medical Hospital (PUMC), Beijing, China

Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment

Phase 3
Completed
Conditions
Other Acute Postoperative Pain
Interventions
First Posted Date
2011-02-25
Last Posted Date
2015-08-11
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
240
Registration Number
NCT01304134
Locations
🇨🇳

Investigational site, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath